IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of IRIDEX (NASDAQ:IRIXFree Report) in a report published on Monday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.

IRIDEX Trading Down 5.3 %

Shares of NASDAQ IRIX opened at $1.07 on Monday. The company’s fifty day moving average is $1.52 and its 200-day moving average is $1.65. The stock has a market cap of $17.80 million, a price-to-earnings ratio of -1.60 and a beta of 0.94. IRIDEX has a twelve month low of $0.96 and a twelve month high of $3.65. The company has a quick ratio of 0.85, a current ratio of 1.54 and a debt-to-equity ratio of 0.55.

IRIDEX Company Profile

(Get Free Report)

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.

Read More

Receive News & Ratings for IRIDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IRIDEX and related companies with MarketBeat.com's FREE daily email newsletter.